U.S. Wireless Telecom Stock News

NYSE:U
NYSE:USoftware

Unity (U) Stock Seems Near Fair Value Following Unity 7 Reveal

Unity Software stock sits in an awkward spot for valuation focused investors, with a share price that has fallen sharply over five years while the broader checks now suggest it is closer to fairly priced than a clear bargain. Over the past five years, Unity Software shareholders have seen the stock decline 73.3%, which sets a low bar for what would count as a convincing recovery story. Recent attention on Unity 7 and talk of potential acquisition interest can support optimism on future cash...
NYSE:PAY
NYSE:PAYDiversified Financial

Paymentus Holdings (PAY) Stock Looks Stretched After A 166% Return

Paymentus Holdings stock has delivered a strong 166.1% return over the past three years, yet its current valuation checks point to a share price that screens as expensive rather than as an obvious bargain. Over the past three years, Paymentus Holdings has returned 166.1%, which puts extra focus on whether the current price still reflects a reasonable expectation for the business. For a payments platform reliant on scaling transaction volumes and managing technology costs, expectations for...
NasdaqCM:SBET
NasdaqCM:SBETCapital Markets

Sharplink (SBET) Stock Still Looks Overvalued Even As Sales Back The Story

Sharplink stock has seen its share price fall very sharply over the past five years, yet today the valuation checks still lean expensive rather than pointing to a clear bargain. Over the last five years, Sharplink’s share price has declined about 99%, which raises questions about how much long term value the current business model can support. Backing for the EthSystems launch may support Sharplink’s role in Ethereum focused privacy solutions. At the same time, execution risk around turning...
NYSE:THG
NYSE:THGInsurance

Should Hanover Insurance Group’s CEO Succession Plan Shape How THG Investors View Its Tech-Led Specialty Strategy?

In July 2026, The Hanover Insurance Group announced that longtime CEO Jack Roche would retire at the end of 2026, with chief operating officer Richard Lavey named CEO-elect and slated to join the board on January 1, 2027, following a brief advisory period for Roche. This planned transition hands the reins to an insider who oversees operations and Hanover Agency Markets, which account for about 75% of the company’s US$7.00 billion in gross premiums written. We’ll now examine how appointing...
NYSE:TMHC
NYSE:TMHCConsumer Durables

Taylor Morrison (TMHC) Is Now Private After Berkshire Hathaway Closes Acquisition

Berkshire Hathaway has completed its acquisition of Taylor Morrison Home, previously listed as NYSE:TMHC. The transaction converts Taylor Morrison Home into a privately held company while keeping its existing management team in place. The company is expected to undergo board and governance changes under the oversight of Berkshire Hathaway. Taylor Morrison stock, which last closed at $72.45, will no longer trade on public exchanges or be included in equity indices. Taylor Morrison Home,...
NYSE:WSM
NYSE:WSMSpecialty Retail

Williams Sonoma (WSM) Could Be 17% Below Fair Value On Earnings Optimism

Williams-Sonoma (WSM) is back in focus as investors look ahead to the company’s upcoming quarterly earnings report, with recent stock moves shaped by its history of outperforming earnings expectations and cautiously positive analyst sentiment. See our latest analysis for Williams-Sonoma. At a share price of $226.74, Williams-Sonoma has seen a 3.72% 1 day share price gain, while its 90 day share price return of 18.99% and 1 year total shareholder return of 26.54% point to momentum that has...
NYSE:CFR
NYSE:CFRBanks

Cullen/Frost Bankers (CFR) Stock Looks Like A Bargain Despite Premium Earnings Pricing

Cullen/Frost Bankers has delivered a 77.5% total return over the past five years, yet its valuation checks send mixed signals, with an intrinsic value estimate from the Excess Returns model suggesting the stock trades at a discount while traditional market multiples lean the other way. A 77.5% five year return can make Cullen/Frost Bankers look like a long term winner, but it also raises the bar for what counts as good value today. Expectation of further earnings strength may support the...
NasdaqCM:AHG
NasdaqCM:AHGHealthcare

The Bull Case For Akso Health Group (AHG) Could Change Following Sharply Narrowed Full-Year Net Loss - Learn Why

Akso Health Group has released its full-year results for the period ended March 31, 2026, reporting sales of US$13.84 million and revenue of US$13.83 million, alongside a net loss of US$18.67 million. While top-line figures were slightly lower than the prior year, the loss per share narrowed to US$0.03, pointing to significantly improved cost control or operational efficiency. We’ll now examine how this sharp reduction in net loss shapes Akso Health Group’s investment narrative and what it...
NYSE:CLF
NYSE:CLFMetals and Mining

Cleveland-Cliffs (CLF) Stock Faces Ongoing Losses As Q2 EPS Miss Undercuts Recovery Narrative

Cleveland-Cliffs (CLF) has just posted Q2 2026 results with revenue of US$5.2 billion and a basic EPS loss of US$0.25, while net income excluding extra items came in at a loss of US$143 million. The company has seen quarterly revenue move from US$4.3 billion in Q4 2025 to US$4.9 billion in Q1 2026 and US$5.2 billion in Q2 2026, as quarterly basic EPS loss narrowed from US$0.44 in Q4 2025 to US$0.41 in Q1 2026 and US$0.25 in Q2 2026. This sets up an earnings season in which investors are...
NYSE:LMT
NYSE:LMTAerospace & Defense

Lockheed Martin (LMT) Stock Looks Like A Bargain As Cash Flow And Earnings Align

Lockheed Martin stock has climbed 79.4% over the past five years, yet Simply Wall St's valuation work suggests the shares may still trade below intrinsic value. Both the Discounted Cash Flow (DCF) estimate and market multiples point to an undervalued setup rather than an overly stretched one. Over the last five years, a 79.4% total return indicates investors have already priced in a lot of good news. The key question is whether the current level still leaves a margin between price and...
NYSE:ABT
NYSE:ABTMedical Equipment

Abbott Laboratories (ABT) Could Be 14% Undervalued On Mixed Earnings And Growth Focus

Abbott Laboratories (ABT) is back on investors’ radar after second quarter 2026 earnings showed higher year over year sales alongside lower net income and earnings per share, refocusing attention on future growth drivers. See our latest analysis for Abbott Laboratories. The latest earnings release appears to have reset expectations for Abbott Laboratories, with the share price up 13.9% over 30 days and 13.1% over 90 days, even as the year to date share price return and one year total...
NYSE:MAIN
NYSE:MAINCapital Markets

The Bull Case For Main Street Capital (MAIN) Could Change Following Questions On Supplemental Dividend Sustainability

Earlier this week, Main Street Capital drew attention as investors looked ahead to its now-upcoming August 6, 2026 earnings report and fresh profit and revenue expectations. The discussion has increasingly centered on how any shift in supplemental dividends and credit conditions could reshape the company’s income profile and perceived value. We’ll now examine how concerns over supplemental dividend sustainability may influence Main Street Capital’s broader investment narrative and...
NYSE:KOF
NYSE:KOFBeverage

Coca Cola FEMSA (KOF) Stock Looks Cheap After A 121% Five Year Run

Coca-Cola FEMSA. de stock has delivered a 120.8% total return over the past 5 years, and today its intrinsic value estimate using a Discounted Cash Flow (DCF) approach points to the shares trading at a discount, while earnings based multiples send a similar undervalued signal. A 120.8% gain over 5 years suggests Coca-Cola FEMSA. de has already rewarded long term shareholders, so any valuation gap now matters more to fresh capital. For the current price to align with the intrinsic value...
NYSE:TMO
NYSE:TMOLife Sciences

Thermo Fisher Scientific (TMO) Stock Faces Margin Stagnation That Tests Bullish Earnings Narrative

Thermo Fisher Scientific (TMO) has just posted its Q2 2026 numbers, with revenue of about US$12.0 billion and basic EPS of US$4.68 helping to shape how investors assess the latest half year, while trailing 12 month EPS sits at US$18.63 on revenue of roughly US$46.3 billion. Over the past few quarters, revenue has moved from US$10.9 billion in Q2 2025 to US$12.0 billion in Q2 2026, and quarterly basic EPS has shifted from US$4.28 to US$4.68. This sets up a results season where margins and...
NasdaqGS:TCOM
NasdaqGS:TCOMHospitality

Trip.com Group (NasdaqGS:TCOM) Faces 5.2b Yuan Antitrust Fine Over Hotel Booking Practices

China's market regulator has imposed a major antitrust fine on Trip.com Group (NasdaqGS:TCOM) related to hotel booking practices. Authorities found the company used exclusive arrangements and technical measures that allegedly restricted competition in online hotel distribution. The decision includes corrective requirements aimed at changing how Trip.com Group works with hotel partners and manages platform access. Trip.com Group is a leading online travel services provider, with hotel...
NasdaqGS:RUN
NasdaqGS:RUNElectrical

Sunrun (RUN) Expands California Power Plant To 425 MW Across 80,000 Homes

Sunrun (NasdaqGS:RUN) is expanding its Californian distributed power plant to support the state grid with 425 MW of peak capacity. The virtual power plant now spans more than 80,000 households equipped with residential battery systems. The portfolio is integrating with two major state grid service programs to provide utility scale support from distributed resources. Sunrun sits at the intersection of residential solar, battery storage, and grid services, and this expanded virtual power...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Zevra Therapeutics (ZVRA) Following EMA Setback Is The Sell Off A Valuation Gap

Zevra Therapeutics (ZVRA) is back in focus after the European Medicines Agency’s CHMP issued a negative opinion on arimoclomol for Niemann Pick disease type C, prompting a planned re examination and a sharp share price reaction. See our latest analysis for Zevra Therapeutics. The CHMP setback has hit sentiment hard in the short term, with Zevra Therapeutics’ share price down 23.92% over one day and 27.18% over 30 days. However, its year to date share price return of 14.21% and three year...
NYSE:RSG
NYSE:RSGCommercial Services

Republic Services (RSG) Stock Looks Undervalued Even After A 95% Run

Republic Services stock has nearly doubled over the past five years, yet the valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples make the shares look expensive. Republic Services has returned about 95.2% over five years, which puts longer term holders in a strong position even though the stock is down 10.5% over the last year. Steady cash flow generation from waste collection and disposal contracts can...
NYSE:A
NYSE:ALife Sciences

Agilent (A) Stock May Be 22% Below Fair Value As HALO Investment Grows

Agilent Technologies stock has delivered a 16.2% return over the past year, yet there is a clear split in what the valuation tools are saying, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while market multiples suggest the shares are pricing in a richer scenario. Agilent Technologies' 16.2% one year return suggests the market has been willing to pay more for its cash flow potential, even without a dramatic re rating. The recent increase in investment in HALO...
NYSE:TDC
NYSE:TDCSoftware

Is Teradata (TDC) Using Autonomous Knowledge To Quietly Redefine Its AI Economics?

In mid-July 2026, Teradata announced that its Teradata Autonomous Knowledge Platform is now generally available across cloud, on‑premises, and hybrid environments, alongside Teradata Cloud on AWS, Teradata Factory for on‑premises AI, and the unified Teradata AI Studio and AI Services suite. This launch signals Teradata’s push to make “autonomous knowledge” a core enterprise capability, combining agentic AI, governance, and flexible pricing models that reflect how AI agents actually consume...
NYSE:VZ
NYSE:VZTelecom

Verizon (VZ) Stock May Be A Bargain At This Price

Verizon Communications has delivered a 66.7% return over the past three years, yet its valuation checks paint a more nuanced picture, with the stock screening as undervalued on market multiples but only scoring moderately on broader value tests. With recent news highlighting both growth initiatives and cost cuts, investors are weighing whether the current price already reflects much of that progress. Over the past three years, Verizon Communications has returned 66.7%, which puts current...
NasdaqGS:UCTT
NasdaqGS:UCTTSemiconductor

Ultra Clean Holdings (UCTT) Stock May Be Fairly Priced As Sales Value Lingers

Ultra Clean Holdings stock has delivered a very large 1 year return, yet the valuation picture appears more balanced. The intrinsic value estimate from a Discounted Cash Flow (DCF) model is close to the current share price, while market-based multiples still point to some undervaluation. Ultra Clean Holdings is up about 287.1% over the past year, which puts extra focus on whether the current price still leaves enough valuation cushion. Expectations for continued cash flow generation from its...
NasdaqGS:PSKY
NasdaqGS:PSKYMedia

Paramount Skydance (PSKY) Following Debt Offer Extension Has An Undervalued Narrative In Focus

Paramount Skydance (PSKY) is back in focus after Discovery affiliates extended the tender and exchange offer deadlines for Warner Bros. Discovery notes. These notes will be swapped into new Paramount debt, in connection with the pending Warner Bros. Discovery acquisition. See our latest analysis for Paramount Skydance. Despite the recent regulatory approvals and the extended debt tender and exchange offers, Paramount Skydance's short term momentum has been weak, with the share price down...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Should Veeva’s Upgraded 2027 Outlook and Q2 Earnings Setup Require Action From Veeva Systems (VEEV) Investors?

In recent days, Veeva Systems prepared to report its fiscal Q2 2027 results after previously raising its fiscal 2027 guidance for revenue and adjusted earnings, drawing heightened analyst attention. This combination of upgraded outlook and approaching earnings has highlighted the tension between generally optimistic brokerage views and more measured ratings that stress caution. We’ll now examine how Veeva’s raised fiscal 2027 guidance, set against mixed analyst ratings, reshapes the...